"App Improves Quality Of Life In IBD Patients" - Alexandria Bachert, MPH
Patients with inflammatory bowel disease (IBD) who used a collaborative disease management app saw a significant improvement in care and quality of life, researchers reported. Among 320 patients with IBD, those randomized to HealthPROMISE – an app designed to increase patient engagement and self-management skills – reported significant improvements in quality of care over a follow-up of 575 days from baseline compared with controls, according to Ashish Atreja, MD, MPH, assistant professor of medicine and gastroenterology at the Icahn School of Medicine at Mount Sinai, director of Sinai ApplLab, and chief technology, innovation and engagement officer at the Mount Sinai Hospital. "IBD patients engaging with HealthPROMISE reported more equitable participation in their care decision-making process, and showed improved health outcomes compared to patients not using HealthPROMISE," said Dr. Atreja. IBD patients are an ideal population to assess the therapeutic potential of a digital intervention used in conjunction with clinical methods for long-term IBD management, researchers added.
- Ashish Atreja, MD, MPH, Assistant Professor, Medicine, Gastroenterology, Icahn School of Medicine at Mount Sinai, Director, Sinai AppLab, Chief Technology, Innovation and Engagement Officer, The Mount Sinai Hospital
Additional coverage: